Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
KAPA
Fundamentals

Kairos Pharma, Ltd.

KAPA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

8.07M
▲1.39M▲20.88%
3 Months Change

Liabilities

992.00k
▼-680.00k▼-40.67%
3 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-03-02
Form 8-K
ID: 0001493152-26-008435
2026-02-26
Form 8-K
ID: 0001493152-26-008116
2025-11-14
Form 10-Q
ID: 0001493152-25-023276
2025-10-15
Form 8-K
ID: 0001493152-25-018145
2025-10-07
Form 8-K
ID: 0001493152-25-017208
2025-09-18
Form 8-K
ID: 0001493152-25-013975
2025-09-11
Form 8-K
ID: 0001493152-25-013040
2025-09-03
Form 8-K
ID: 0001641172-25-026316
2025-08-12
Form 10-Q
ID: 0001641172-25-023167
2025-07-15
Form 8-K
ID: 0001641172-25-019645